• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (63)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Amyotrophic Lateral Sclerosis  • Cognitive Disorders  • Dementias  • Neuromuscular diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Jennifer M. Murphy, PhD; Roland G. Henry, PhD; Susan Langmore, PhD; Joel H. Kramer, PsyD; Bruce L. Miller, MD; Catherine Lomen-Hoerth, MD, PhD

Arch Neurol. 2007;64(4):530-534.

Objective  To identify the nature and prevalence of cognitive and behavioral abnormalities in patients with amyotrophic lateral sclerosis (ALS).

Design  Survey of clinical characteristics.

Setting  Multidisciplinary clinic within a university medical center.

Patients  A volunteer sample of 30 new patients with ALS were recruited consecutively. Of those invited, 23 participants (20 with sporadic ALS and 3 with familial ALS) enrolled. Participants ranged in age from 27 to 80 years (mean age, 56.5 years); the education level ranged from 12 to 21 years (mean education level, 3.5 years of college); and 17 participants (74%) were male.

Main Outcome Measures  Neuropsychological tests, neurobehavioral interviews, and structured magnetic resonance imaging.

Results  Patients were classified into subtypes of frontotemporal lobar degeneration (n = 5), suspected Alzheimer disease (n = 1), and subthreshold variants of cognitive impairment (n = 2), behavioral impairment (n = 4), and cognitively and behaviorally normal (n = 11). Five neuropsychological tests, 2 behavioral abnormalities, and right hemisphere gray matter reductions differentiated patients into normal and abnormal groups.

Conclusions  In this sample, a sizable proportion of patients with ALS possess a range of behavioral and cognitive changes that lie on a spectrum of frontotemporal impairment. Right hemisphere atrophy may be a biomarker for cognitive impairment in patients with ALS.

Author Affiliations: Department of Neurology, ALS Center (Drs Murphy, Langmore, and Lomen-Hoerth), Department of Radiology, Center for Molecular and Functional Imaging (Dr Henry), and Department of Neurology, Memory and Aging Center (Drs Kramer and Miller), University of California, San Francisco.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations
Snowden et al.
Brain 2012;0:awr355v1-awr355.
ABSTRACT | FULL TEXT  

Predicting survival in frontotemporal dementia with motor neuron disease
Coon et al.
Neurology 2011;76:1886-1892.
ABSTRACT | FULL TEXT  

The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis
Agosta et al.
Am. J. Neuroradiol. 2010;31:1769-1777.
ABSTRACT | FULL TEXT  

Cognitive and behavioural deficits associated with the orbitomedial prefrontal cortex in amyotrophic lateral sclerosis
Meier et al.
Brain 2010;133:3444-3457.
ABSTRACT | FULL TEXT  

Management of Dysarthria and Dysphagia in Patients With Amyotrophic Lateral Sclerosis
Graner and Strand
Neurophysiology and Neurogenic Speech and Language Disorders 2010;20:39-44.
ABSTRACT | FULL TEXT  

TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration
Wils et al.
Proc. Natl. Acad. Sci. USA 2010;107:3858-3863.
ABSTRACT | FULL TEXT  

FUS Mutations in Familial Amyotrophic Lateral Sclerosis in the Netherlands
Groen et al.
Arch Neurol 2010;67:224-230.
ABSTRACT | FULL TEXT  

TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Wegorzewska et al.
Proc. Natl. Acad. Sci. USA 2009;106:18809-18814.
ABSTRACT | FULL TEXT  

Survival Profiles of Patients With Frontotemporal Dementia and Motor Neuron Disease
Hu et al.
Arch Neurol 2009;66:1359-1364.
ABSTRACT | FULL TEXT  

Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Miller et al.
Neurology 2009;73:1227-1233.
ABSTRACT | FULL TEXT  

Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies
Igaz et al.
J. Biol. Chem. 2009;284:8516-8524.
ABSTRACT | FULL TEXT  

TDP-43 Proteinopathy in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis: Protein Misfolding Diseases Without Amyloidosis
Neumann et al.
Arch Neurol 2007;64:1388-1394.
ABSTRACT | FULL TEXT